Accelerated Restoration of Ocular Surface Health in Dry Eye Disease by Self-Retained Cryopreserved Amniotic Membrane

被引:1
作者
Cheng, Anny M. S. [1 ,2 ]
Zhao, Dandan [3 ]
Chen, Rendian [4 ]
Yin, Han Y. [5 ]
Tighe, Sean [1 ,2 ]
Sheha, Hosam [1 ,2 ]
Casas, Victoria [1 ,2 ]
Tseng, Scheffer C. G. [1 ,2 ]
机构
[1] Ocular Surface Ctr, Miami, FL 33173 USA
[2] Tissuetech Inc, Miami, FL USA
[3] YanAn Hosp Kunming City, Dept Ophthalmol, Kunming, Yunnan, Peoples R China
[4] Shenzhen Childrens Hosp, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China
[5] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA
关键词
amniotic membrane; dry eye; keratitis; ocular surface; PROKERA (R); STEM-CELL DEFICIENCY; ACTIVATED MACROPHAGES; STROMAL MATRIX; WORKSHOP; 2007; TRANSPLANTATION; CORNEAL; SUPPRESSION; KERATITIS; DISORDERS; APOPTOSIS;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the clinical efficacy of self-retained cryopreserved amniotic membrane in treating dry eye disease. Methods: Retrospective review of 10 patients treated with self-retained cryopreserved amniotic membrane (PROKERA (R) Slim [PKS], Bio-Tissue, Miami, FL) for moderate-to-severe dry eye refractory to conventional maximal medical treatments. Patients' symptoms, use of medications, conjunctival inflammation, corneal staining, and visual acuity were compared before and after treatment. Results: PKS was placed in 15 eyes of the 10 patients for 4.9 +/- 1.5 days. All patients experienced symptomatic relief for a period of 4.2 +/- 4.7 months (P<.001). Such improvement was accompanied by reduction of OSDI scores (P<.001), use of topical medications (P<.001), conjunctival hyperemia (P<.001), corneal staining (P<.001), and improvement of the visual acuity (P=.06). Linear regression analysis estimated that the optimal duration of PKS placement was 5 days to achieve an average symptom-free duration of 4 months in patients with dry eye. Surprisingly, PKS placement also generated improvement in the contralateral eyes. Conclusion: This pilot study suggests that self-retained cryopreserved amniotic membrane via PKS can be used to treat moderate dry eye diseases and warrants further prospective controlled studies.
引用
收藏
页码:56 / 63
页数:8
相关论文
共 52 条
[31]   The diagnosis and management of dry eye - A twenty-five-year review [J].
Pflugfelder, SC ;
Solomon, A ;
Stern, ME .
CORNEA, 2000, 19 (05) :644-649
[32]  
Pflugfelder Stephen C, 2008, Am J Manag Care, V14, pS102
[33]   Reliability and validity of the ocular surface disease index [J].
Schiffman, RM ;
Christianson, MD ;
Jacobsen, G ;
Hirsch, JD ;
Reis, BL .
ARCHIVES OF OPHTHALMOLOGY, 2000, 118 (05) :615-621
[34]   Efficacy and Limitation of Sutureless Amniotic Membrane Transplantation for Acute Toxic Epidermal Necrolysis [J].
Shay, Elizabeth ;
Khadem, John J. ;
Tseng, Scheffer C. G. .
CORNEA, 2010, 29 (03) :359-361
[35]   Amniotic Membrane Transplantation as a New Therapy for the Acute Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis [J].
Shay, Elizabeth ;
Kheirkhah, Ahmad ;
Liang, Lingyi ;
Sheha, Hossam ;
Gregory, Darren G. ;
Tseng, Scheffer C. G. .
SURVEY OF OPHTHALMOLOGY, 2009, 54 (06) :686-696
[36]  
Sheha H, 2013, Ocular surface disorder, V39th, P325
[37]   Sutureless Amniotic Membrane Transplantation for Severe Bacterial Keratitis [J].
Sheha, Hosam ;
Liang, Lingyi ;
Li, Jianjing ;
Tseng, Scheffer C. G. .
CORNEA, 2009, 28 (10) :1118-1123
[38]   Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders [J].
Shimmura, S ;
Shimazaki, J ;
Ohashi, Y ;
Tsubota, K .
CORNEA, 2001, 20 (04) :408-413
[39]  
Smith JA, 2007, OCUL SURF, V5, P93
[40]   Suppression of interleukin 1α and interleukin 1β in human limbal epithelial cells cultured on the amniotic membrane stromal matrix [J].
Solomon, A ;
Rosenblatt, M ;
Monroy, D ;
Ji, ZH ;
Pflugfelder, SC ;
Tseng, SCG .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (04) :444-449